Diagnosis and management of hirsutism

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 166-174

  Escobar Morreale, Héctor F ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

chlormadinone; cyproteone acetate; drosperinone; electrolysis; finasteride; flutamide; hirsutism; idiopathic hyperandrogenism; oral contraceptives; photoepilation; polycystic ovary syndrome; spironolcatone

Indexed keywords

ANDROGEN; ANTIANDROGEN; CHLORMADINONE ACETATE; CYPROTERONE ACETATE; DESOGESTREL; DIANE; EFLORNITHINE; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; GESTAGEN; GESTODENE; INSULIN SENSITIZING AGENT; METFORMIN; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE;

ADD ON THERAPY; ANDROGEN BLOOD LEVEL; ANDROGEN RELEASE; ANTIANDROGEN THERAPY; AREA UNDER THE CURVE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMINIZATION; HIRSUTISM; HUMAN; HYPERANDROGENISM; IDIOPATHIC DISEASE; LIVER TOXICITY; MEDICAL HISTORY; MENSTRUATION DISORDER; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; OVULATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PREVALENCE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; TRANSVAGINAL ECHOGRAPHY; VIRILIZATION; BLOOD; ENDOCRINE SYSTEM EXAMINATION; FEMALE;

ANDROGENS; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HIRSUTISM; HUMANS;

EID: 77957077500     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05652.x     Document Type: Conference Paper

References (33)

1. Martin, K.A. et al. 2008. Evaluation and treatment of hirsutism in premenopausalwomen: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93: 1105-1120.
2. Olsen, E.A. 1999. Methods of hair removal. J. Am. Acad. Dermatol. 40: 143-155.
3. Azziz, R. et al. 2006. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91: 4237-4245.
4. Azziz, R., E. Carmina & M.E. Sawaya. 2000. Idiopathic hirsutism. Endocr. Rev. 21: 347-362.
5. Escobar-Morreale, H.F. et al. 1997. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 46: 902-907.
6. Rosner,W. et al. 2007.Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab. 92: 405-413.
7. Garn, S.M. 1951. Types and distribution of the hair in man. Ann. N.Y. Acad. Sci. 53: 498-507.
8. Ferriman, D. & J.D. Gallwey. 1961. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21: 1440-1447.
9. Lorenzo, E.M. 1970. Familial study of hirsutism. J. Clin. Endocrinol. 31: 556-564.
10. Hatch, R. et al. 1981. Hirsutism: implications, etiology, and management. Am. J. Obstet. Gynecol. 140: 815-830.
11. Api, M. et al. 2009. Interobserver variability of modified Ferriman-Gallwey hirsutism score in a Turkish population. Arch. Gynecol. Obstet. 279: 473-479.
12. Rosenfield, R.L. 2005.Hirsutism.N.Engl. J.Med. 353: 2578-2588.
13. Knochenhauer, E.S. et al. 1998. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. J. Clin. Endocrinol. Metab. 83: 3078-3082.
14. Asunción, M. et al. 2000. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85: 2434-2438.
15. Tellez, R.&J. Frenkel. 1995. [Clinical evaluation of body hair in healthy women]. Rev. Med. Chil. 123: 1349-1354.
16. Cheewadhanaraks, S., K. Peeyananjarassri& C. Choksuchat. 2004. Clinical diagnosis of hirsutism in Thai women. J.Med. Assoc. Thai. 87: 459-463.
17. Escobar-Morreale, H.F., R. Sanchon & J.L. SanMillan. 2008. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J. Clin. Endocrinol. Metab. 93: 527-533.
18. Azziz, R. et al. 1998. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil. Steril. 70: 274-278.
19. White, P.C. & P. W. Speiser. 2000. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21: 245-291.
20. American Diabetes Association. 2008. Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1): S55-60.
21. Matsuda, M. & R.A. DeFronzo. 1999. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
22. Lord, J.M., I.H. Flight & R.J. Norman. 2003. Insulinsensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst RevCD003053.
23. Luque-Ramirez, M. et al. 2007. The increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism, and do not result from reduced menstrual losses. Diabetes Care 30: 2309-2313.
24. Luque-Ramirez, M. et al. 2007. Comparison of ethinylestradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92: 2453-2461.
25. Luque-Ramirez, M. et al. 2008. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinylestradiol plus cyproterone acetate versus metformin. Hum. Reprod. 23: 1594-1601.
26. Luque-Ramirez, M. et al. 2009. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking. Eur. J. Endocrinol. 160: 469-480.
27. Luque-Ramirez, M., F. Alvarez-Blasco & H.F. Escobar- Morreale. 2009. Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obesity (Silver Spring) 17: 3-9.
28. Luque-Ramirez, M. et al. 2009. Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome. Fertil. Steril. 91: 2527-2536.
29. Fruzzetti, F. et al. 1999. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects. Fertil. Steril. 71: 445-451.
30. Moghetti, P. et al. 2000. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 85: 89-94.
31. Levitt, J.I. 1970. Spironolactone therapy and amenorrhea. JAMA 211: 2014-2015.
32. Van Wayjen, R.G. & A. van den Ende. 1971. Clinicalpharmacological investigation of cyproterone acetate. Gynecol. Invest. 2: 282-289.
33. Wallace, C., E.A. Lalor & C.L. Chik. 1993. Hepatotoxicity complicating flutamide treatment of hirsutism. Ann. Intern. Med. 119: 1977.